INTRODUCTION
Extracellular aggregation and accumulation of the amyloid-b (Ab) peptide in different forms, including plaques within the hippocampus and neocortex, is one hallmark pathology of Alzheimer's disease (AD) (Selkoe, 2001) . Within the brain, Ab is primarily produced within neurons by cleavage of the amyloid precursor protein (APP) followed by secretion into the brain interstitial fluid (ISF) . Within the ISF, Ab is found in its normal, soluble form throughout life. During the pathogenesis of AD, Ab aggregates into forms that include insoluble species and probably soluble Ab oligomers, both of which have been demonstrated under particular circumstances to be toxic to cells or to disrupt synaptic plasticity. While the initial polymerization seed for Ab aggregates may form intracellularly or extracellularly (Gouras et al., 2000; Meyer-Luehmann et al., 2003) , it is likely that much of the peptide necessary for Ab aggregation as well as plaque formation and growth is derived from the soluble ISF pool of Ab. Conversion of soluble Ab into either plaques or oligomers is concentration dependent, meaning that elevated levels of ISF Ab are likely to hasten the formation of these toxic species. Consequently, knowing the factors that regulate ISF Ab levels has implications for understanding disease pathogenesis as well as for developing therapeutics.
Although molecular events surrounding secretase cleavage of APP are well understood, the cellular processes regulating Ab production and the subsequent release of Ab by neurons are less characterized. Neuronal activity modulates Ab levels. Activation of muscarinic M1 acetylcholine receptors increases a-secretase cleavage of APP and consequently reduces Ab levels in animal models as well as in humans (Caccamo et al., 2006; Nitsch et al., 2000) . Activation of NMDA receptors decreases a-secretase cleavage, thereby increasing Ab levels (Lesne et al., 2005) . Lesions of the cortical axon fibers that project to the dentate gyrus substantially reduce Ab accumulation in APP transgenic mice (Lazarov et al., 2002; Sheng et al., 2002) . Additionally, modulating synaptic transmission alters extracellular soluble Ab levels in organotypic brain slice (Kamenetz et al., 2003) . Using APP transgenic and wild-type mice, our group demonstrated that synaptic activity dynamically modulates ISF Ab levels in vivo (Cirrito et al., 2005) . Hippocampal seizures induced by electrical stimulation increased ISF Ab levels by 30% within 30 min. Conversely, decreasing synaptic transmission using tetrodotoxin (TTX) or tetanus toxin rapidly reduced ISF Ab levels by 30% and 80%, respectively.
In acute brain slices, synaptic vesicle cycling alone, in the absence of neuronal depolarization, was sufficient to drive release of Ab from neurons (Cirrito et al., 2005) . Because Ab is not located within synaptic vesicles (Ikin et al., 1996; Marquez-Sterling et al., 1997) , we hypothesized that an event closely associated with vesicle exocytosis is actually the underlying mechanism responsible for Ab production and release from neurons. Cell culture experiments have shown that full-length APP is retrieved from the cell surface via clathrin-mediated endocytosis (Nordstedt et al., 1993) , then APP is cleaved by b-secretase (BACE) and g-secretase within late and early endosomes to produce Ab (Lah and Levey, 2000; Vassar et al., 1999) . Ab produced in the endocytic pathway is then brought to the cell surface where it is released into the extracellular fluid (Koo et al., 1996) . Inhibition of endocytosis reduces APP internalization and reduces Ab production and release in cell lines (Carey et al., 2005; Koo and Squazzo, 1994) . During synaptic transmission, synaptic vesicles fuse with the plasma membrane, followed by the synaptic vesicle membrane being retrieved from the cell surface, at least in part via clathrin-mediated endocytosis (Maycox et al., 1992) . Within synaptosomes, clathrin-coated vesicles contain APP as well as several synaptic vesicle proteins, including synaptophysin, synaptotagmin I, and SV2 (Marquez-Sterling et al., 1997) . This suggests that synaptic proteins and APP can be internalized from the plasma membrane together via a common pathway. Because synaptic activity leads to elevated endocytosis of synaptic vesicle-related proteins, we hypothesized a synaptic activity-induced increase in endocytosis also drives more APP into the endocytic compartment, ultimately resulting in increased Ab production and release. Herein, we provide direct evidence for this hypothesis in the brain in vivo.
RESULTS
Ab is primarily produced within neurons and secreted into the brain ISF. In order to assess ISF Ab levels in living mice, we utilized an in vivo microdialysis technique that enables serial sampling of molecules within the brain ISF (Cirrito et al., 2003) . Microdialysis probes were implanted unilaterally into the hippocampus of 3-month-old Tg2576 APP transgenic mice (Hsiao et al., 1996) . Following probe implantation under volatile anesthesia, mice remained awake with freedom of movement throughout the experiment. ISF Ab levels were assessed every 30-60 min for up to 24 hr, enabling us to determine basal ISF Ab levels and then intervene pharmacologically to assess the effect on ISF Ab levels over time within the same mouse. In addition to measuring Ab levels, microdialysis also permits the direct administration of small molecular weight compounds into the hippocampus via reverse microdialysis. Using this procedure, we administered compounds to the exact region of tissue from which Ab was sampled. In a subset of mice, dual recording electrodes were attached to the microdialysis probe assembly to record electrical field potentials near sites of Ab measurement (Cirrito et al., 2005) .
Inhibition of Endocytosis Reduces ISF Ab Levels In Vivo
We hypothesized that Ab released into the brain ISF following synaptic transmission requires an intermediate event involving APP endocytosis. We first assessed the influence of endocytosis on ISF Ab levels under normal conditions. A dynamin dominantnegative inhibitory peptide (dynamin-DN) was infused directly into the hippocampus by reverse microdialysis. Dynamin-DN blocks dynamin binding to amphiphysin, thus inhibiting scission of clathrin-coated vesicles from the plasma membrane. This myristylated, cell-permeable peptide has been shown in cell culture to inhibit clathrin-mediated endocytosis (Marks and McMahon, 1998) . In vivo, dynamin-DN reduced biotinylated transferrin uptake into cells within the dentate gyrus, confirming the in vivo effectiveness of this peptide at reducing endocytosis (see Figure S1 available online).
Basal ISF Ab levels were established in 3-month-old Tg2576 APP transgenic mice over 8 hr, followed by 4 hr of continuous administration of dynamin-DN ( Figure 1A ). At this age, Tg2576 mice do not contain Ab deposits, and Ab metabolism can be studied without the complicating factor of Ab aggregates (Hsiao et al., 1996) . Within 30 min of dynamin-DN treatment, ISF Ab levels were significantly decreased, with a maximal decrease of 70% by hour four of treatment ( Figure 1A ). This is similar to studies in cell culture demonstrating that inhibition of endocytosis reduces Ab levels in media (Koo and Squazzo, 1994) . Following treatment, dynamin-DN was removed from the microdialysis perfusion buffer, and ISF Ab levels were measured for an additional 8 hr. Within 2 hr of washout, Ab levels increased transiently by 250% over baseline levels and returned to basal levels within 8 hr. ISF Ab levels did not change significantly in mice treated with vehicle or in mice treated with 200 mM scrambled peptide ( Figure 1A) . Similarly, ISF levels of the neuropeptide orexin (also called hypocretin) were also unchanged in response to dynamin-DN infusion (see Figure S2 available online).
To determine the dose of dynamin-DN that maximally reduces ISF Ab levels in vivo, Tg2576 mice were administered a dose escalation of inhibitory peptide ( Figure 1B ). Dynamin-DN had an IC 50 of 100.4 ± 5.9 mM in vivo, with a dose of 200 mM maximally reducing ISF Ab levels ( Figure 1C ). These data demonstrate that inhibition of clathrin-mediated endocytosis can dramatically reduce ISF Ab levels in vivo.
To assess the effect of dynamin-DN on cell-surface APP levels, we treated a Neuro2A (N2A) neuroblastoma cell line that expresses APP695 (Thinakaran et al., 1996) with dynamin-DN or a myristylated, scrambled control peptide for 4 hr. Inhibition of endocytosis increased cell-surface APP fluorescence by 50% compared to the control peptide treatment ( Figure S3A ). Dynamin-DN treatment did not alter total APP expression levels in this cell line; however, it significantly reduced APP b-CTF levels ( Figure S3B ). Dynamin-DN also significantly decreased Ab levels within the cells by 30% ( Figure S3C ). Consistent with the effects of dynamin-DN, another less specific inhibitor of clathrin-mediated endocytosis, chlorpromazine (Wang et al., 1993) , reduced ISF Ab levels in vivo by 20% ( Figure S4 ). Together, the data demonstrate that dynamin-DN reduces APP endocytosis, cleavage by b-secretase, and thus Ab generation.
Inhibition of Endocytosis Does Not Depress Synaptic Transmission
Clathrin-mediated endocytosis is required for a variety of cellular functions, including, in part, the recycling of synaptic vesicle membrane in order to replenish the readily releasable pool of synaptic vesicles (Heuser and Reese, 1973) . Inhibition of dynamin can deplete synaptic vesicles (Newton et al., 2006) . Interestingly, genetic deletion of dynamin I in mice does not affect spontaneous synaptic transmission; however, it can result in depressed evoked postsynaptic potentials, especially following trains of strong exogenous stimuli (Ferguson et al., 2007) . Because depressed synaptic activity reduces Ab release (Cirrito et al., 2005; Kamenetz et al., 2003) , it is conceivable that dynamin-DN may reduce ISF Ab levels by inhibiting synaptic activity and not necessarily by having a direct effect on APP endocytosis or Ab generation. In order to test this possibility during inhibition of endocytosis, we assessed neuronal activity using spontaneous field potential recordings as well as evoked potential recordings.
Dual recording electrodes assessed extracellular field potentials, or depth EEG, within the hippocampus at the same location that Ab was measured and that dynamin-DN was administered ( Figure 1D ). Inhibition of endocytosis did not alter the amplitude ( Figure 1E ) or frequency ( Figure 1F ) of EEG activity within the hippocampus at any point during administration. Mice remained awake with freedom of movement throughout these recordings.
Therefore, these results suggest that global neurotransmission was not dramatically altered by dynamin-DN at the doses utilized.
EEG records spontaneous, physiological neuronal activity within a large volume of brain tissue and may not be sensitive to subtle, local changes in activity. Consequently, we assessed evoked field EPSPs (fEPSPs), which provides a more direct assessment of synaptic transmission within the hippocampus in an awake, behaving animal. Bipolar stimulating electrodes were implanted into the medial perforant pathway. In the same animal, a microdialysis probe with dual recording electrodes was implanted into the dentate gyrus, enabling evoked fEPSP measurement and local dynamin-DN administration ( Figure 1G ). Dynamin-DN did not change the initial slope of the fEPSP measured at either 15 min, 2 hr, or 4 hr of administration compared to The initial slope of the fEPSP did not change during 4 hr of dynamin-DN treatment; however, when the perfusion buffer was changed to contain 10 mM TTX, the fEPSP was significantly reduced by 89.8% ± 3.8% within 15 min of treatment (p < 0.0001, n = 3). (I) Likewise, fEPSP slope was similar under basal and dynamin-DN treatment during 1 Hz trains of stimuli for 60 s (n = 3). Data presented as mean ± SEM. **p < 0.001, ***p < 0.0001. basal recordings from the same mouse ( Figure 1H ). Given that dynamin-DN produced a negative result, we sought to confirm that a change in fEPSP could be detected if an appropriate compound was infused into the brain. Following dynamin-DN administration, the perfusion buffer was changed to contain tetrodotoxin (TTX), a sodium channel blocker that should potently inhibit evoked fEPSPs. Within 15 min of TTX treatment, the fEPSP slope was reduced by 95% and was undetectable by 1 hr of treatment. Single fEPSPs were not inhibited by dynamin-DN, so we also determined if trains of stimuli could elicit a difference in fEPSP slope. Stimuli at 1 Hz for 60 s also did not result in a difference in the evoked EPSP slope between basal and dynamin-DN conditions ( Figure 1I ). The reduction in fEPSP slope in both groups over the course of the train is typical for this type of recording using medial perforant pathway stimulation (McNaughton, 1980) . Given that neither spontaneous EEG activity nor evoked fEPSPs were altered in the presence of dynamin-DN, it does not appear that inhibition of endocytosis substantially affects synaptic transmission in vivo at normal, spontaneous levels or at low frequencies of stimulation. These data suggest that the small, remaining portion of clathrin-mediated endocytosis is capable of sustaining normal synaptic transmission or that some dynamin-1-independent mechanisms of vesicle retrieval are active (Ferguson et al., 2007 ). It appears from our data that administration of dynamin-DN does not adversely affect in vivo synaptic transmission over the timescale that we assessed.
Activity-Dependent Elevation of ISF Ab Levels Requires Endocytosis
Synaptic transmission dynamically modulates ISF Ab levels in vivo. Depression of synaptic activity reduces ISF Ab levels whereas seizures rapidly increase Ab levels in Tg2576 mice (Cirrito et al., 2005) . We sought to determine if subtle increases in synaptic transmission could also elevate ISF Ab levels and if endocytosis was required for the activity-dependent Ab production and release. Tg2576 mice were treated with 25 mM picrotoxin, a noncompetitive GABA A receptor antagonist, via reverse microdialysis ( Figure 2A ). Picrotoxin caused a significant 50% increase in ISF Ab levels by 4 hr of administration ( Figure 2B ). In contrast, dynamin-DN reduced ISF Ab levels and prevented the increase in Ab levels when coadministered with picrotoxin. While high doses of picrotoxin can generate seizures, the low dose used here only produced occasional spikes in synchronous EEG activity ( Figure 2C ). Similar spikes in EEG activity also occurred during dynamin-DN and picrotoxin coadministration. As a consequence of picrotoxin treatment, the amplitude of EEG activity increased similarly in both dynamin-DN and vehicle-treated mice ( Figure 2D ).
Metabotropic glutamate receptors 2/3 (mGluR2/3) are expressed presynaptically to modulate glutamate release. When these receptors are inhibited, glutamate release from the presynaptic terminal is enhanced (Losonczy et al., 2003) . LY341495, a mGluR2/3 antagonist, was administered directly into the hippocampus to increase synaptic activity during microdialysis to determine the effect on ISF Ab levels ( Figure 3A ). LY341495 caused a gradual increase in ISF Ab levels to 20% of baseline over 8 hr ( Figure 3B ). In the presence of LY341495 and dynamin-DN, Ab levels were not increased compared to dynamin-DN alone. The effects of both picrotoxin and LY341495 on ISF Ab levels were prevented by inhibiting endocytosis. This suggests that endocytosis was a key event linking elevated synaptic activity and release of Ab into the brain ISF in Tg2576 mice.
One concern regarding any transgenically expressed protein is that it could be regulated and processed differently than the endogenous protein. Consequently, we assessed the link between synaptic activity, endocytosis, and murine ISF Ab 40 and Ab 42 levels in 3-month-old C57Bl6 wild-type mice. Because murine Ab levels are substantially lower and more difficult to detect than human Ab in Tg2576 mice, we sampled ISF Ab levels over 12 hr periods instead of every 30 min (Figure 4 ). Similar to Tg2576 mice, 25 mM picrotoxin increased murine ISF Ab 40 and Ab 42 levels by 130% over baseline. Dynamin-DN reduced ISF Ab 40 and Ab 42 levels by 60% and 75%, respectively. Interestingly, the greater decrease in Ab 42 than Ab 40 was statistically significant. A subset of mice was pretreated with dynamin-DN for 1 hr, then coadministered picrotoxin for 12 hr. Ab levels in these mice were not statistically different than those treated with dynamin-DN alone. That endocytosis is a key event linking synaptic activity and Ab generation in wild-type mice underscores that this phenomenon is part of a normal pathway for Ab production.
Inhibition of Endocytosis Does Not Affect ISF Ab Elimination
It is possible that inhibition of endocytosis could affect both ISF Ab production and ISF Ab elimination. In the case of Ab production, endocytosis is required for internalization of full-length APP prior to Ab generation (Koo and Squazzo, 1994) . In the case of elimination, molecules such as LRP1 have been shown to internalize Ab directly or bound to apoE (Deane et al., 2004) . In order to determine if inhibition of endocytosis modulates ISF Ab elimination, we measured the half-life of ISF Ab in Tg2576 mice treated with vehicle or dynamin-DN. Basal ISF Ab levels were determined, followed by administration of dynamin-DN or vehicle for 4 hr, after which mice were injected with a potent g-secretase inhibitor (LY411575) subcutaneously to rapidly inhibit g-secretase activity and Ab production ( Figure 5A ) (Cirrito et al., 2003) . ISF Ab elimination followed first-order kinetics in both vehicle and dynamin-DN treated mice ( Figure 5B ). The half-life of ISF Ab was approximately 1 hr in both groups (Figure 5C ), which is similar to previously published values for this mouse model (Cirrito et al., 2005; Yin et al., 2006) . This demonstrates that dynamin-DN does not dramatically affect ISF Ab elimination. Though this assay may be insensitive to subtle changes in Ab elimination, it suggests that inhibition of endocytosis alters ISF Ab levels via changes in Ab production and release following APP internalization and not via changes in Ab clearance.
Distinct Pathways for ISF Ab Generation
Both inhibition of synaptic activity (Cirrito et al., 2005) and inhibition of endocytosis reduce ISF Ab levels. In order to determine the extent that activity and endocytosis each contribute to ISF Ab levels, we coadministered TTX and dynamin-DN. If dynamin-DN was administered first, ISF Ab levels declined by a maximum of 70% ( Figures 6A and 6B) . If the microdialysis perfusion buffer was then switched to contain dynamin-DN and TTX, there was no additional change in ISF Ab levels. This suggests that all of the ISF Ab that is produced due to synaptic activity requires endocytosis. Conversely, if animals were pretreated with TTX, followed by dynamin-DN coadministration, then ISF Ab levels were further reduced when endocytosis was inhibited ( Figures  6C and 6D ). This demonstrates that there is a pool of ISF Ab that is generated via endocytosis that is not affected by synaptic activity but remains sensitive to dynamin-DN.
DISCUSSION
Many studies have postulated that the aggregation of Ab in both soluble and insoluble forms in the brain is likely a key initiating factor in AD pathogenesis. Thus, influences on the aggregation process are potentially major treatment targets. Since the process of Ab aggregation is concentration dependent, understanding factors that regulate Ab levels in the location that it aggregates (e.g., in the brain extracellular space) is likely to provide critical insights into the biology of AD. While it has been demonstrated that APP endocytosis is a key step in Ab generation and In C57Bl6 mice, 25 mM picrotoxin increased ISF murine Ab 40 and Ab 42 levels to 133.4% ± 2.3% and 131.5% ± 6.1%, respectively (p < 0.0001), of baseline over 12 hr. Two-hundred micromolar dynamin-DN reduced murine Ab 40 levels to 38.3% ± 2.8% (p < 0.0001) and Ab 42 levels to 23.8% ± 0.8% of baseline (p < 0.0001). Ab 42 levels were significantly more reduced than Ab 40 levels (p < 0.0001; noted by ###). Pretreatment with dynamin-DN for 1 hr then coadministration of dynamin-DN and picrotoxin caused ISF Ab 40 and Ab 42 levels to decrease to 43.9% ± 3.7% and 18.9% ± 1.5% of baseline, which was not statistically different from dynamin-DN treatment alone. n = 6 per group. Data presented as mean ± SEM. ***p < 0.0001. release in vitro, we provide direct evidence that inhibition of clathrin-mediated endocytosis reduces ISF Ab levels in awake mice, both transgenic and wild-type, under normal conditions. Importantly, in addition to endocytosis, our work shows that synaptic activity, and specifically synaptic vesicle exocytosis, is linked with neuronal Ab release. Utilizing two distinct pharmacological interventions, we found that increasing synaptic activity increases ISF Ab levels in a manner dependent on endocytosis. Clathrin-mediated endocytosis of APP is necessary for activitydependent regulation of ISF Ab levels in APP transgenic mice as well as in wild-type mice. This emphasizes that these results elucidate a normal pathway for regulating ISF Ab levels. Blockade of endocytosis primarily affected Ab generation with no detectable change in ISF Ab elimination. We estimate that the majority of ISF Ab in vivo is generated through endocytosis of APP and that, in the brain, synaptic activity plays a primary role in that process. Overall, these findings define a pathway by which synaptic activity influences Ab release into brain ISF that is likely relevant to AD pathogenesis.
One major pathway for Ab generation is endocytosis of fulllength APP from the plasma membrane into the endocytic compartment, where BACE and g-secretase act to produce Ab. Ab is then subsequently secreted from the neuron into the extracellular space. Our hypothesis is that synaptic activity drives more APP into the endocytic compartment, thus increasing Ab generation and release. Action potential invasion of the synaptic terminal causes calcium influx ( Figure 7A ). Calcium causes synaptic vesicles to fuse with the plasma membrane and to release neurotransmitter into the synaptic cleft ( Figure 7B ). This is the basis of synaptic transmission. As more synaptic vesicles fuse with the plasma membrane, there is an increase in the amount and overall rate of endocytosis that recycles the vesicular membrane from the cell surface. When the synaptic vesicle membrane is recycled from the plasma membrane via clathrin-mediated endocytosis, more APP is internalized as well ( Figure 7C ). It is possible that calcium entry may also cause endocytosis through other mechanisms, such as synthesis of PI(4,5)P 2 , which recruits the clathrin assembly and mediates clathrin-mediated endocytosis (Wenk et al., 2001) . Increased endocytosis increases APP internalization into the endocytic compartment where Ab is generated ( Figure 7D ). Once generated, Ab can be secreted from the neuron into the brain extracellular space ( Figure 7E ).
Our previous studies provide direct evidence that Ab is generated due to presynaptic mechanisms; causing synaptic vesicle exocytosis with a-latrotoxin in the absence of postsynaptic activation is still capable of generating Ab (Cirrito et al., 2005) . We cannot rule out a postsynaptic mechanism as well, however. a-Latrotoxin in the presence of postsynaptic activation has a greater effect on extracellular Ab than a-latrotoxin in the absence of the postsynaptic activation. The difference between these two conditions ($20% of Ab generation) is likely due to postsynaptic mechanisms that also influence Ab generation (Cirrito et al., 2005) .
Two mechanistically distinct agents increased synaptic activity and increased ISF Ab levels. Picrotoxin inhibits ionotropic GABA A receptors, thus increasing synaptic transmission by reducing inhibition of excitatory neurons. In contrast, LY341495 blocks perisynaptic G protein-coupled mGluR2/3, thus increasing excitatory neurotransmission by directly enhancing glutamate release at the synapse. Both of these pathways increased Ab levels by modestly increasing synaptic activity. In both cases, inhibition of endocytosis completely blocked the elevation of the ISF Ab levels. This phenomenon was also observed with wildtype murine Ab 40 and Ab 42 levels. Interestingly, inhibition of endocytosis had a larger effect on Ab 42 levels than Ab 40 , perhaps suggesting that a greater percentage of extracellular Ab 42 comes from endosomes than does Ab 40 .
Dynamin-DN reduced ISF Ab levels by over 60%. However, washout of dynamin-DN caused a transient surge in ISF Ab levels. This suggests that APP may have been retained on the cell surface during inhibition of endocytosis and comprised a large pool of substrate capable of generating Ab when endocytosis resumed. In the in vivo paradigm, for Ab production to be elevated Several studies have demonstrated that Ab, particularly oligomeric species, can modulate various aspects of synaptic transmission (Hsieh et al., 2006; Shankar et al., 2007; Ting et al., 2007; Townsend et al., 2006) . Our studies demonstrate that inhibition of endocytosis has no effect on spontaneous EEG activity or evoked potentials in vivo. Interestingly, blocking endocytosis reduced ISF Ab levels by 70% but did not appear to modulate transmission. Given that Ab levels were not reduced to zero, it is possible that the remaining 30% of ISF Ab was sufficient to retain Ab's effect, if any, on synaptic transmission. It is also likely that the majority of ISF Ab present in 3-month-old Tg2576 mice is monomeric and not oligomeric Ab. Further studies are required to address what role Ab has on synaptic activity in vivo.
The data suggest there are at least three cellular mechanisms that contribute to ISF Ab production. First, a pathway that is synaptic activity dependent (TTX sensitive) and endocytosis dependent, which contributes to approximately 60% of ISF Ab levels in Tg2576 mice. Second, a pool of ISF Ab that requires endocytosis but is independent of synaptic activity. This pathway is responsible for another 10% of ISF Ab levels. Interestingly, inhibition of endocytosis does not reduce ISF Ab levels to zero. The remaining pool of Ab, comprising 30% of total ISF Ab levels, may be the product of several mechanisms, including Ab produced within the secretory pathway (Busciglio et al., 1993) or Ab diffusing from brain areas that are not affected by dynamin-DN or TTX. Alternatively, this last pool may be a factor of incomplete inhibition of endocytosis or some small contribution of altered Ab elimination. These values provide rough estimates for each of these pools and provide an interesting framework to consider the various pathways that contribute to the overall pool of ISF Ab. A source of 70% of ISF Ab in vivo is a tantalizing target for therapeutic development. While inhibiting all clathrin-mediated endocytosis is unlikely to be a feasible strategy for lowering extracellular Ab levels, it may be possible to modulate individual components of the endocytic machinery or synaptic transmission to selectively affect Ab generation.
Several molecules influence the rate and amount of APP endocytosis. LRP1 expression increases the rate of APP endocytosis from the plasma membrane, whereas LRP1b expression (B) Dynamin-DN reduced ISF Ab levels to 33.0% ± 3.2% of baseline over 12 hr (p < 0.0001), and coadministration with TTX did not additionally change Ab levels compared to dynamin-DN alone (n = 4 per group). (C) Mice were either treated with 10 mM TTX alone for 12 hr or with TTX for 8 hr followed by TTX and 200 mM dynamin-DN together for an additional 4 hr. Ten micromolar TTX alone for 12 hr reduced ISF Ab levels to 41.8% ± 3.2% of baseline (p < 0.0001, n = 8). When TTX was coadministered with dynamin-DN, ISF Ab levels decreased to 30.0% ± 1.4% of baseline (p < 0.0001, n = 5). The 7% difference between TTX and TTX with dynamin-DN was significant (p < 0.05). Data presented as mean ± SEM. *p < 0.05. reduces the rate of internalization (Cam et al., 2004 (Cam et al., , 2005 . Recent evidence also implicates another LDL-R family member, LR11 or SorLa, in modulating APP trafficking through the endosomal compartment (Andersen et al., 2005; Dodson et al., 2006; Offe et al., 2006; Rogaeva et al., 2007) . LR11 overexpression increases APP colocalization within the Golgi and reduces Ab generation in culture, whereas deletion of the LR11 gene in mice increases brain Ab levels (Andersen et al., 2005) . Given that several LDL-R family members modulate Ab endocytosis, it will be important to elucidate if and how these molecules affect synaptic activity-dependent Ab generation.
While our studies do not directly assess where Ab is produced or released, it is likely that Ab generation that is caused by events within the synaptic terminal would occur at or near the synapse. Kamenetz and colleagues demonstrated that neurons virally expressing APP can depress synaptic transmission in nearby neurons (Kamenetz et al., 2003) . This also suggests that Ab released from a neuron might even be able to feed back to inhibit activity within the same neuron. We have identified a mechanism of Ab production and release near the synapse that is intimately associated with synaptic activity. This phenomenon produces a situation whereby synaptically released Ab is positioned to modulate synaptic activity. The conformation of Ab that is released following synaptic activity will likely be a critical factor for modulation of neurotransmission. For instance, Ab oligomers appear to be much more potent at depressing synaptic transmission than Ab monomers (Townsend et al., 2006) . The Ab conformations that are released at synapses and whether those Ab species change with age or disease stage is unknown.
Synaptic activity appears to affect Ab levels in humans as well. First, a fraction of patients with temporal lobe epilepsy develop diffuse Ab deposits in seizure-prone brain regions as early as 30 years of age (Gouras et al., 1997; Mackenzie and Miller, 1994) . Second, there are several links between stress, neuronal activity, and AD. Individuals that are prone to psychological distress are more likely to develop AD (Wilson et al., 2005; Wilson et al., 2003) . Also, plasma levels of the stress hormone cortisol are correlated with the rate of dementia progression in patients with AD (Csernansky et al., 2006) . In APP-transgenic mice subjected to restraint stress, ISF Ab levels are significantly higher than control animals; however, the acute increase in Ab levels is blocked in the absence of neuronal activity (Kang et al., 2007) . Final support for the idea of a casual link between synaptic activity and Ab levels in humans comes from recent brain-imaging studies. Brain regions that contain the most metabolic activity throughout life, and presumably have the highest levels of neuronal activity, are also the regions most vulnerable to Ab accumulation and aggregation in AD patients (Buckner et al., 2005) . In each of these cases, synaptic activity appears to play a role in regulating Ab levels under physiologic conditions. We now identify a cellular pathway, endocytosis, that likely links synaptic activity and Ab production.
EXPERIMENTAL PROCEDURES Animals
All experimental procedures involving animals were performed in accordance with guidelines established by the Animal Studies Committee at Washington University. We bred Tg2576 +/À hemizygous mice (a generous gift from Dr. K.
Ashe, University of Minnesota) to wild-type C57Bl6/SJL mice (Taconic Farms, Germantown, NY), then aged the Tg2576 +/À offspring to 3-5 months for use in experiments. Animals were screened for the Tg2576 transgene by PCR from tail DNA. Three-month-old C57Bl6 mice were ordered from Jackson Laboratory (Bar Harbor, ME).
Compounds
All pharmacological agents were purchased from Sigma-Aldrich (St. Louis, MO) unless otherwise noted. Dynamin dominant-negative (Dynamin-DN) inhibitory peptide (myristylated) and control scrambled peptide were purchased from Tocris Biosciences (Ellisville, MO). The mGluR2/3 antagonist LY341495 and g-secretase inhibitor LY411575 were kind gifts from Darryle Schoepp and Patrick May (Eli Lilly and Company, Indianapolis, IN). All compounds were diluted in microdialysis perfusion buffer and administered via reverse microdialysis, with the exception of LY411575, which was diluted in Mazola corn oil and administered subcutaneously.
Ab ELISA ISF Ab levels were assessed using sandwich ELISAs as described (Cirrito et al., 2003) . Briefly, to assess human Ab 1-x , a central domain, mouse monoclonal antibody (m266) was used to capture and a biotinylated N-terminal human Ab-specific antibody (m3D6) was used to detect, followed by streptavidinpoly-HRP-20 (Fitzgerald Industries, Concord, MA). Human Ab 1-40 and human Ab 1-42 was assessed similar to Ab 1-x ; however, mouse monoclonal antibodies m2G3 and m21F12, respectively, were used as coating antibodies. Murine Ab x-40 was assessed using an Ab 40 -specific mouse monoclonal antibody, mHJ2, as a coating antibody and a biotinylated central domain antibody, mHJ5.1, as the detecting antibody, followed by streptavidin-poly-HRP-40 (Fitzgerald Industries). All ELISA assays were developed using Super Slow ELISA TMB (Sigma, St. Louis, MO) and absorbance read on a Bio-Tek FL-600 plate reader (Winooski, VT) at 650 nm.
In Vivo Ab Microdialysis
In vivo microdialysis to assess brain ISF Ab 1-x in the hippocampus of awake, freely moving Tg2576 mice was performed similar to previously described (Cirrito et al., 2003) . This technique samples soluble molecules within the extracellular fluid that are smaller than 30 kDa, the molecular weight cut off of the probe membrane. Ab capable of entering the probe has been dubbed ''exchangeable Ab,'' or ''eAb'' (Cirrito et al., 2003) . Under isoflurane volatile anesthetic, guide cannula (BR-style, Bioanalytical Systems, Indianapolis, IN) were cemented into the left hippocampus (bregma À3.1 mm, 2.5 mm lateral to midline, and 1.2 mm below dura at a 12 angle).
Two-millimeter microdialysis probes were inserted through the guides so that the membrane was contained entirely within the hippocampus (BR-2, 30 kDa MWCO membrane, Bioanalytical Systems). Microdialysis perfusion buffer was artificial CSF containing 0.15% bovine serum albumin that was filtered through a 0.1 mM membrane. Flow rate was a constant 1.0 ml/min. Samples were collected every 30-60 min with a refrigerated fraction collector into polypropylene tubes and assessed for Ab by ELISA at the completion of each experiment. Basal levels of ISF Ab were defined as the mean concentration of Ab over 6-8 hr preceding drug treatment. For each animal, all Ab levels were normalized to the basal Ab concentration. Once basal ISF Ab levels were established, Tg2576 mice were treated with a variety of compounds by reverse microdialysis. Compounds or vehicle were diluted in 0.15% BSA-aCSF perfusion buffer. Murine ISF Ab 40 levels were assessed using a similar protocol, except longer sample times of 12 hr at a 0.5 ml/min flow rate were necessary to concentrate ISF samples. For each mouse, the basal concentration of Ab was established over 12 hr of collection followed by 12 hr treatment with either dynamin-DN, picrotoxin, or cotreatment with dynamin-DN and picrotoxin. In the latter group, dynamin-DN was pretreated for 1 hr prior to cotreatment with picrotoxin.
EEG Recording
To record EEG activity, bipolar recording electrodes (Teflon-coated, stainlesssteel wire, 0.0055 inch coated OD, A-M Systems, Carlsborg, WA) were attached to the shaft of the microdialysis guide cannula with Elmer's Super-Fast Epoxy Resin (Elmer's, Columbus, OH). Electrodes extended $1 mm from the tip of the guide, so that the electrode tip was located at the center of the 2 mm microdialysis membrane. EEG activity was assessed using a P511K A.C. Pre-amplifier (Grass Instruments, Quincy, MA), digitized with a DigiData 1322A Data Acquisition System (Axon Instruments, Union City, CA), and recorded digitally using pClamp 9.2 (Axon Instruments). EEG amplitude standard deviation and frequency power spectrum were assessed for 15 min epochs for 4 hr prior treatment and during 4 hr of dynamin-DN treatment.
Evoked Field Potential Recordings Microdialysis was performed as described previously; however, implant coordinates were altered to coincide with optimized perforant pathway stimulation. The stimulating electrode (model SNE-200X-35, Rhodes Medical, Summerland, CA) was implanted at bregma À4.3 mm, 2.9 mm lateral to midline, at $1.2-1.6 mm below dura. Recording electrodes were designed similar to EEG recording electrodes except the electrode tips extended approximately 0.5 mm beyond the tip of the microdialysis probe. Guide cannula were inserted at coordinates À2.5 mm, 1.3 mm lateral to midline, and 1.5-1.9 mm below dura. The precise location of the recording and stimulating electrodes was optimized based on the fEPSP waveform produced during placement. Two bone screws were used; one had a grounding wire attached. The cannula/electrode assembly was then cemented to the skull using a binary dental cement (Bioanalytical Systems). The DigiData 1322A and stimulus isolator (World Precision Instruments, Sarasota, FL) were used to deliver evoked potentials.
Field EPSPs were evoked by a constant current stimulus (0.1 ms duration) that produced a 50% max slope as determined by an input-output curve. The slope of the initial fEPSP was assessed using pClamp version 9.2 software. Single fEPSPs were assessed at a frequency of 0.017 Hz at various times before and during drug treatments. In each animal, dynamin-DN was treated by reverse microdialysis for 4 hr; then the perfusion buffer was changed to contain TTX for 1 hr. Trains of fEPSPs were assessed at 1 Hz just prior to treatment and after 4 hr of dynamin-DN administration.
Ab Elimination Half-Life ISF Ab half-life was determined as described (Cirrito et al., 2003) . Microdialysis probes were inserted as described previously. Basal levels of ISF Ab were established for 4 hr, followed by administration of dynamin-DN or vehicle via reverse microdialysis for the remainder of the experiment. Four hours after treatment began, LY411575, a potent, blood-brain barrier permeable g-secretase inhibitor (Eli Lilly and Co, Indianapolis, IN), was administered subcutaneously at 3 mg/kg body weight in corn oil. Samples were collected every 30 min for an additional 1 hr, then assessed for Ab 1-x by ELISA.
Statistical Analysis
Data in figures represent mean ± SEM. All statistical analysis was performed using Prism version 5.01 for Windows (GraphPad, San Diego, CA). Statistical analysis was performed using a one-way ANOVA with Bonferroni post-test. Values were accepted as significant if p % 0.05.
SUPPLEMENTAL DATA
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